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Understanding the physical characteristics of the local microenvironment in which Mycobacterium tubercu-
losis resides is an important goal that may allow the targeting of metabolic processes to shorten drug regimens.
Pimonidazole hydrochloride (Hypoxyprobe) is an imaging agent that is bioreductively activated only under
hypoxic conditions in mammalian tissue. We employed this probe to evaluate the oxygen tension in tuberculous
granulomas in four animal models of disease: mouse, guinea pig, rabbit, and nonhuman primate. Following
infusion of pimonidazole into animals with established infections, lung tissues from the guinea pig, rabbit, and
nonhuman primate showed discrete areas of pimonidazole adduct formation surrounding necrotic and caseous
regions of pulmonary granulomas by immunohistochemical staining. This labeling could be substantially
reduced by housing the animal under an atmosphere of 95% O2. Direct measurement of tissue oxygen partial
pressure by surgical insertion of a fiber optic oxygen probe into granulomas in the lungs of living infected
rabbits demonstrated that even small (3-mm) pulmonary lesions were severely hypoxic (1.6  0.7 mm Hg).
Finally, metronidazole, which has potent bactericidal activity in vitro only under low-oxygen culture conditions,
was highly effective at reducing total-lung bacterial burdens in infected rabbits. Thus, three independent lines
of evidence support the hypothesis that hypoxic microenvironments are an important feature of some lesions
in these animal models of tuberculosis.
Active human pulmonary tuberculosis (TB) is a chronic,
complex disease in which patients present a diverse spectrum
of lesions ranging from diffuse areas of inflammation and
swelling of alveoli to caseous, highly organized granulomas and
open cavities in intimate contact with the airways (9, 25). Com-
puted tomography (CT) has been used to study defined types
of lesions and the rate of response of such lesions to chemo-
therapy. Open cavities, caseous lesions, centrilobular densities
(i.e., nodules or branching linear structures of 2 to 4 mm in
length that are well separated from the pleural surface or the
septum between pulmonary lobes), ground-glass opacities, and
tissue consolidations are all apparent in active tuberculosis
patients by use of this technique (17, 24, 30). The most com-
prehensive study of CT findings during TB chemotherapy was
that of Im and colleagues (17), who studied CT scans of pa-
tients undergoing TB chemotherapy for up to 20 months and
then compared their findings with postmortem autopsy results
to assist in interpretation. In this study there were significant
differences in the rates at which different lesion types re-
sponded to chemotherapy.
Surgical lung resection has been employed periodically as
salvage therapy for patients who have failed chemotherapeutic
treatment, and the resected tissues have proven useful for
studying the heterogeneity of lesions that can occur within a
single infected person (19, 40, 41). Studies on surgically re-
moved tissues have revealed that most TB lesions contain
surprisingly few bacilli, except for the surfaces of open cavities
(19, 25, 41). Cavities are the best-oxygenated TB lesions, and
most have the same oxygen tension as the communicating
bronchi at apparently normal atmospheric oxygen tension (15).
The bacteria within such aerobic environments are likely to be
highly susceptible to conventional chemotherapies. Caseous
necrotic lesions are also abundant in resected lung tissue, with
thick multicellular walls insulating them from the airways of
the host, and these have been reported to contain relatively
fewer bacilli (21, 41). In this environment, it appears that the
bacteria are less responsive to current chemotherapy (41);
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thus, increasing attention has been given to understanding the
physiology of caseous, necrotic granulomas and the tubercle
bacilli within them.
Within these lesions, the bacteria may exist in a state of
nonreplicating persistence, during which they may have ac-
quired a phenotypic resistance to antimycobacterial drugs (13,
26). The chemical and physical characteristics of the human
microenvironments containing these nonreplicating bacilli are
not known; however, since the 1950s, it has been postulated
that reduced oxygen tension may be one essential feature (35–
37). This concept underlies the in vitro models of hypoxia-
induced nonreplicating persistence in which the growth of the
organism is arrested by oxygen depletion (44). In this in vitro
hypoxic state, Mycobacterium tuberculosis becomes phenotypi-
cally resistant to first-line antituberculosis agents such as iso-
niazid and ethambutol and shows reduced susceptibility to
killing with rifampin (Rif) while acquiring a unique suscepti-
bility to metronidazole (Mtz) (43, 45).
Recently, several studies have used hypoxia-imaging agents
to demonstrate that mice infected with M. tuberculosis (which
fail to produce highly organized caseous or necrotic lesions) do
not develop hypoxic regions within their infected lungs (3, 39).
However, in C57BL/6 mice infected with Mycobacterium avium
strain TMC724, more-organized caseous pulmonary lesions
that are positive for the hypoxia marker pimonidazole hydro-
chloride (PIMO) have been clearly shown (3). Guinea pigs
have also been shown to produce a population of caseous
lesions positive for PIMO (23). Experiments comparing
C57BL/6 and gamma-interferon-deficient mice suggest that
imbalanced angiostatic and angiogenic signals controlling neo-
vascularization may contribute to caseation (2). PIMO is an
investigational oncology probe used as a hypoxia-imaging
agent in clinical studies to detect reduced oxygen concentra-
tions in animal and human tumors (31–33). PIMO is able to
diffuse across cell membranes and is bioreductively activated
by mammalian nitroreductases at a partial pressure of oxygen
(pO2) below 10 mm Hg (14 M) (12, 31). Upon activation,
PIMO binds to thiol-containing peptides and proteins in hy-
poxic cells that can be detected in biopsy specimens by anti-
bodies to the PIMO protein adduct (4, 5, 32). The oxygen
concentration required for productive PIMO activation is low
compared to the oxygen concentrations in venous blood and
lung tissue, and the unbound agent is cleared rapidly, resulting
in highly selective labeling of tissue regions that are hypoxic.
In this study, several models of TB were compared in order
to try to assess the state of oxygenation of the tuberculous
granuloma using the oncology probe PIMO. We found that
guinea pigs, rabbits, and nonhuman primates all have lesions in
the lung that stain with this probe but that murine lesions do
not. The rabbit model was used to confirm that PIMO staining
of TB lesions was oxygen responsive, and direct measurement
of pO2 using an oxygen-sensitive electrode showed that the
oxygen tension was 2 mm Hg in these granulomas. Finally,
Mtz, a drug active only against hypoxic TB, was shown to be
active in rabbit infections, though it had failed to show activity
in murine infections in previous investigations.
MATERIALS AND METHODS
Animals and human subjects. The studies using C57BL/6 and BALB/c mice,
New Zealand White (NZW) rabbits, outbred Hartley strain guinea pigs, and
adult cynomolgus macaques were performed with the approval of the animal
care and use committees of NIAID, Texas A&M University, and the University
of Pittsburgh. Human lung tissue collection from adult patients undergoing lung
resection for the management of multidrug-resistant TB was approved by the
National Masan Tuberculosis Hospital (NMTH) institutional review board and
granted an exemption by the U.S. National Institutes of Health, Office of Human
Subject Research. Resected lung tissue was collected for this research collabo-
ration between NIAID and NMTH with written consent from the patients.
Bacteria and infection of animals. Mycobacterium tuberculosis strain HN878
(J. Musser),M. tuberculosisCDC1551 (Centers for Disease Control and Prevention),
M. tuberculosis Erdman, M. tuberculosis H37Rv, and Mycobacterium bovis Ravenel
and AF2122 (American Type Culture Collection) were maintained on Middlebrook
7H11 agar and frozen as described previously (34). The aerosol inocula were pre-
pared by diluting these frozen stocks to 1 105 to 1.5 105 CFU/ml in phosphate-
buffered saline (PBS)–Tween 80 (0.05%) (8). Guinea pigs were infected by low-dose
aerosol as described previously with M. tuberculosis strain CDC1551 or H37Rv, and
lungs were harvested at 4 and 8 weeks postinfection (46).
For infection of rabbits, frozen aliquots of M. bovis Ravenel or AF2122 or M.
tuberculosis HN878 were inoculated into Middlebrook 7H9 medium (1:20), in-
cubated with rolling for approximately 8 to 10 days, and adjusted to an optical
density at 650 nm of 0.7. This culture was diluted 1:300 in PBS and loaded into
a three-jet nebulizer (CH Technologies). Female rabbits (weight, 2.0 to 2.4 kg)
were restrained in veterinary bags with hoods and loaded into the nose-only
exposure tubes. This solution delivered approximately 200 CFU/liter of infec-
tious aerosol and generated 50 to 100 granulomas per rabbit lung. Animals (n 
3) used to determine bacterial deposition were harvested 2 h postinfection.
Cynomolgus macaques (4 years old) were infected via bronchoscopic instil-
lation of a low dose (25 CFU per monkey) of M. tuberculosis strain Erdman
into the right lower lung as previously described (7). M. tuberculosis infection was
confirmed by conversion of a negative tuberculin skin test to positive and by a
lymphocyte proliferation assay in response to mycobacterial antigens. Monkeys
were followed with serial clinical, radiographic, microbiologic, and immunologic
assays. A total of eight monkeys were used in this study. Four of the monkeys
developed active TB requiring necropsy. These represented a variety of clinical
courses, including those with rapid progression after infection, worsening chronic/
active disease, and spontaneous reactivation after latent infection (7). Two mon-
keys had clinically latent infections but were euthanized as part of other inves-
tigations. Two other monkeys had latent infections but were euthanized due to
non-TB-related complications.
Treatment with PIMO, necropsy, and tissue preparation. The dose of PIMO
for mice (30 to 60 mg/kg of body weight intraperitoneally [i.p.] for 2 h) was that
recommended by the manufacturer. Doses that produced strong PIMO labeling
of the kidney with little or no background in normal lungs were as follows: for
guinea pigs, 30 mg/kg i.p. for 4 h; for rabbits, 30 mg/kg intravenously (i.v.) or i.p.
for 16 to 20 h; for macaques, 20 mg/kg i.v. for 20 to 24 h. In some experiments,
the oxygen content of the animal’s atmosphere was altered using a ProOx con-
troller and an A chamber (BioSpherix, Redfield, NY). Rabbits were exposed to
95% O2 by the addition of Carbogen for 4 h prior to PIMO injections and for
16 h after administration. Control animals were housed in normal room air, and
they were necropsied and their tissues processed and stained at the same times
as those from altered O2 atmospheres.
Mice were euthanized by cervical dislocation, and dissected lung and kidney
tissues were preserved in 10% neutral buffered formalin for 24 h before paraffin
embedding and processing. Guinea pigs were euthanized as described previously
(22). Lung and kidney tissues were fixed in 10% neutral buffered formalin for a
minimum of 24 h before paraffin embedding and processing. Rabbits were
sedated with ketamine/xylazine, euthanized by i.v. injection of sodium pentobar-
bital (120 mg/kg), and immediately necropsied. The entire accessory lobe and
slices of the remaining lobes were preserved in 4% paraformaldehyde in PBS
(pH 7.4) (20) or 10% neutral buffered formalin for a minimum of 24 h, pro-
cessed, and embedded in low-temperature paraffin wax.
At the time of necropsy, nonhuman primates were sedated (ketamine) and a
lethal dose of pentobarbital was administered. Normal and granulomatous lung
tissues were excised, fixed in 10% normal buffered formalin for at least 24 h, and
then paraffin embedded. Resected human lung tissue was immediately dissected.
Gross lesions were identified by type and subdivided for fixation as described above.
Staining and immunohistological identification of PIMO adducts. The extensive
development of PIMO as an agent for imaging hypoxia within tissues has iden-
tified several tissues with regions that are normally hypoxic, including the tubules
of the kidney (47). Throughout this study, we assayed the kidney of each exper-
imental animal in the same staining run as the lung samples to confirm PIMO-
positive staining of the kidney prior to scoring the lung tissue and granulomas for
the presence or absence of PIMO adducts. For each tissue block, 5-m-thick
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consecutive sections were prepared, and serial sections were stained with stan-
dard hematoxylin and eosin (H&E), the Ziehl-Neelsen acid-fast procedure, and
the Hypoxyprobe-1 antibody for PIMO. For detection of PIMO adducts in
animal tissues, paraffin sections were deparaffinized, treated with cell conditioner
1, and incubated in succession with the Hypoxyprobe-1 antibody (1:50) for 40
min at room temperature, followed by a biotin-conjugated goat anti-mouse
immunoglobulin G antibody (1:2,000; Vector Laboratories) for 32 min, the DAB
(3,3-diaminobenzidine) labeling system (Ventana Medical Systems), and hema-
toxylin counterstaining for 4 min using a Ventana Discovery XT autoimmunos-
tainer (Ventana Medical Systems). After staining, slides were washed with 2%
Dawn (Procter and Gamble), dehydrated, and mounted with Cytoseal 60 (Rich-
ard Allen Scientific). Photographic images were captured through a Zeiss
Axioskop microscope equipped with a Plan-Neofluar lens using a Retigna 1300
cooled QImaging camera and were analyzed using IPLab 3.6.1 software (Scana-
lytics Inc.).
Classification of granulomas into solid or caseous types. A direct terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL)
assay (In Situ Cell Death detection kit; Roche) was conducted on paraffin sec-
tions containing granulomas. Prior to the assay, the sections were deparaffinized
and subjected to a short sodium citrate treatment using a Ventana Discovery
IHC processor. The terminal transferase (TdT) and fluorescein-dUTP reaction
mixture was added to the slides and incubated at 37°C to label free 3 OH ends
in genomic DNA. For each tissue, a negative control without TdT and a positive
control where the section had been exposed to DNase I for 10 min prior to the
TUNEL reaction were prepared and examined. The treated sections were placed
on coverslips and viewed under a fluorescence microscope. Two of three inde-
pendent readers scored each histology specimen in the study. During scoring,
sections were coded so that animal tracking numbers and their treatments were
obscured from the readers. Each reader classified granulomas by type using
H&E-stained tissue sections as well as sections subjected to the TUNEL reac-
tion. The readers scored the coded tissue sections labeled with the anti-PIMO
antibody separately from the H&E-stained and TUNEL-stained sections; then a
master list of animal tissue specimens, the lesions that each contained, their
classification, and their staining status was constructed.
Thoracotomy procedure and oxygen measurement. NZW rabbits were in-
fected with 300 CFU of M. tuberculosis strain HN878 (n  3) or 30 CFU of M.
bovis (n  4) as described above, and the infection was allowed to develop for 6
to 8 weeks prior to the thoracotomy procedure. Measurements of pO2 were also
taken for uninfected, age-matched rabbits (n  3) housed in the same facility.
Prior to surgery, each rabbit was administered PIMO (16 h prior) and glyco-
pyrrolate, and each was sedated using a ketamine, xylazine, and Acepromazine
mixture (20 min) prior to insertion of a 3.5-mm cuffed endotracheal tube and an
angiocatheter into the lateral ear vein for i.v. saline and venous access. The tube
was connected to a Bain Circuit with a rebreathing bag, and isoflurane anesthesia
(1 to 1.5%) was supplied with medical air (21% oxygen). Supplemental heat was
supplied by securing the animal in the left lateral recumbency on a prewarmed
recirculating water blanket, and the right side was clipped and disinfected. Blood
oxygen saturation, heart rate, and body temperature were measured continu-
ously, and blood oxygen saturation remained at or above 92 during the proce-
dures. A lidocaine line block was placed in the fifth intercostal space, and an
incision was made through the skin and muscle to the pleura. The thoracic cavity
was entered using blunt-tipped surgical scissors, causing the lung to collapse
away from the thoracic wall. After this incision, the lungs were volume ventilated
mechanically or manually 30 to 40 times/min to maintain normal oxygenation.
Retractors were used to spread the ribs, and the lobes of the lung were manip-
ulated using padded forceps.
Tissue pO2 was measured with a four-channel fiber optic oxygen sensor (Oxy-
Lite 4000  Oxydata; Oxford Optronix, Oxford, United Kingdom). Each probe
(BF/OT/E pO2/Temp sensor) was calibrated by the manufacturer and identified
through a bar code scanned into the OxyLite sensor prior to use. The system uses
a pulse of blue light (470 nm) to excite a platinum-based fluorophore embedded
in a silicone matrix on the tip of the fiber and measures the duration of the
resultant fluorescent signal. Since oxygen quenches the signal, the higher the
dissolved O2 concentration at the tip of the fiber, the shorter the fluorescent
signal. The signal was converted as a function of temperature within the system
to report absolute pO2 in mm Hg at 1-s intervals. The data were digitized using
the Oxydata system and transferred for analysis in PowerLab Chart (version
4.2.4) software (ADI Instruments, Castle Hill, Australia).
Although the probes were precalibrated, the operation of each probe was
confirmed by taking pO2 measurements of humidified, 35 to 37°C air (151 mm
Hg) and nitrogen-saturated PBS (1 to 3 mm Hg). We also measured blood pO2
in the right atrium chamber (40 mm Hg) and the fourth intercostal muscle
(25 mm Hg) at least once during each surgical procedure. For each rabbit,
alternating measurements were taken in apparently normal lung and granulo-
matous lesions in the right medial and caudal lobes; for one rabbit, the right
cranial lobe was also accessible to the probe. Each measurement was taken by
inserting the needle-sheathed probe through the plural surface of the lung and
then retracting the needle to position the probe tip 2 mm into the targeted
tissue. The probe was maintained in position for 1 to 2 min in each location.
After the measurements were made or if the animal’s vital signs became unsta-
ble, the animal was euthanized using Beuthanasia-D administered via the i.v.
catheter, and a full necropsy was completed.
Drug treatment of rabbits and mice, and statistical analysis. Rabbits were ha-
bituated to receive 2 ml of raspberry-flavored syrup by a 3-ml syringe daily for 3
weeks prior to drug treatment. Metronidazole benzoate (80 mg/ml) and Rifadin
IV (rifampin at 20 mg/ml) were prepared and offered orally in raspberry syrup.
The Rif solution was prepared and used within 15 min of mixing with syrup.
Beginning 5 weeks after infection, the rabbits were treated with either 20 mg/kg
Mtz twice daily, 10 mg/kg Rif once daily, or syrup alone for 4 weeks. During
necropsy, the entire right midlobe was weighed and homogenized in 6 ml of
M7H9 medium for CFU determination. Individual granulomas and normal tis-
sue from the remaining lung were dissected, sized, and homogenized for CFU
determination. Our experiments did not culture any M. bovis Ravenel in the
rabbit spleen after 4 weeks.
Mice were infected with M. bovis Ravenel as previously described for M.
tuberculosis (34). Beginning 5 weeks after infection, the mice were gavaged with
either 20 mg/kg Mtz twice daily, 10 mg/kg Rif once daily, or PBS alone for 28
consecutive days. The doses were chosen to attempt to simulate the expected
human exposure to these two agents on the basis of the fact that 10 mg/kg Rif
gives a maximal concentration in serum of 10 g/ml in mice (18), approximately
the same as the maximal concentration in the sera of humans after ingestion of
a single 600-mg dose (29). Interspecies allometric scaling of exposure generally
correlates with the weight of the animal; thus, the exposure of rabbits should be
lower than that of mice but still slightly higher than that of humans (38). After
a single 500-mg dose of oral Mtz in humans, maximal concentrations in serum
are approximately 5 to 10 g/ml (16). Preliminary studies with rats indicate that
after a 15-mg/kg oral dose of Mtz, maximal serum drug concentrations are also
approximately 10 g/ml (V. Dartois, unpublished data). For C57BL/6 mice given
Mtz in their drinking water, serum drug concentrations were 5.9 g/ml, suggest-
ing comparable exposure for this species (5). During necropsy, the right lung and
spleen were homogenized separately in 1 ml of M7H9 medium, diluted, and
spread on M7H11 agar for CFU determination. One-way analysis of variance
(ANOVA) assuming a Gaussian population distribution and Bonferroni’s mul-
tiple-comparison test were used to compare the CFU data.
RESULTS
Pimonidazole labeling in M. tuberculosis-infected mice. M.
tuberculosis strain H37Rv and a hypervirulent, hypoimmuno-
genic clinical isolate (HN878) were used to infect C57BL/6
mice (n  6 for each group) and BALB/c mice (n  3 for each
group) by low-dose aerosol exposure (34). After a chronic
infection was well established (90 to 120 days), 60 mg/kg PIMO
was administered to the infected groups and to three age-
matched uninfected control animals. Two hours later, the an-
imals were sacrificed, and the extent of PIMO protein adduct
formation was assessed in both the kidney tubules and lungs of
infected and uninfected animals. Infected mice had numerous
sites of granulomatous inflammation in their lungs but no areas
of necrosis in the lung endothelium (Fig. 1A). No significant
PIMO staining of lung granulomatous tissue was observed in
the infected animals (Fig. 1B), nor did the normal lung sections
show any significant labeling. In total, 18 chronically infected
animals with 92 granulomas were examined, and no labeling of
lung granulomas was observed after PIMO administration
(Fig. 2B).
Pimonidazole labeling in M. tuberculosis-infected guinea
pigs. A total of 13 guinea pigs infected with M. tuberculosis
were dosed with PIMO 4 h before sacrifice at 4 weeks (4
animals) and 8 weeks (9 animals) postinfection. One hundred
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fifty-five granulomas ranging from 0.1 to 5 mm in width were
identified in right upper lobe tissue sections, and 46% of these
were classified as solid, while 54% were caseous necrotic gran-
ulomas (Fig. 2A). Most solid granulomas were found to be
negative for PIMO activation (Fig. 1E and F). All of the lesions
classified as caseous necrotic lesions showed evidence of in-
tense PIMO activation (Fig. 1H), and the PIMO staining co-
localized with the necrotic region, often subtending an acellu-
lar region that was present in some, but not all, necrotic lesions
(Fig. 1G). In contrast, only 17% of the granulomas scored as
solid without apparent necrosis showed evidence of PIMO
activation (Fig. 2B). These solid granulomas without observ-
able PIMO activation were all0.5 mm in diameter. Extensive
areas of diffuse inflammatory infiltration that were uniformly
PIMO negative were observed in the lungs of these animals.
Pimonidazole labeling in M. tuberculosis-infected rabbits.
Twelve NZW rabbits were infected via aerosol with M. bovis
Ravenel for 8 weeks before administration of PIMO, with eutha-
nasia following 16 to 20 h later. The granulomas observed in these
animals ranged from 0.5 to 8 mm in diameter. In lung sections
from these rabbits, 224 total granulomas were identified and an-
alyzed; 26% of these lesions were scored as solid and 74% as
caseous necrotic (Fig. 1I to L and 2A). All caseous necrotic
granulomas showed clear evidence of PIMO activation (Fig. 2B),
while in contrast, only 32% of the solid granulomas were positive
for PIMO activation. The immunohistochemical staining for
PIMO activation in these solid granulomas, however, was less
intense than that seen in necrotic granulomas (data not shown).
Pimonidazole labeling in M. tuberculosis-infected cynomolo-
gous macaques. Eight cynomolgus macaques, in disease states
ranging from active to latent infection, were administered PIMO
20 to 24 h prior to necropsy. A total of 270 granulomas from the
lungs of these animals were evaluated. Thirty-four percent of
these lesions were classified as solid granulomas lacking central
FIG. 1. Comparison of solid and caseous granulomas as revealed by H&E staining and anti-PIMO adduct labeling. Shown are granulomas from
mice (A and B), humans (C and D), guinea pigs (E to H), rabbits (I to L), and macaques (M to P) infected with M. tuberculosis complex. Solid
granulomas, lacking necrosis, are seen in human disease (C) and in each of the animal models (A, E, I, and M) and do not label strongly with PIMO
(B, F, J, and N). In contrast, caseous necrotic granulomas (D, G, K, and O) have cellular regions that, in the guinea pig, rabbit, and macaque models
displaying these lesions, form PIMO adducts (H, K, and P; brown coloration), indicating low oxygen tension. The murine strains lacked caseous
granulomas and were not labeled with an anti-PIMO adduct antibody. The inset in panel B shows murine kidney staining with an anti-PIMO
antibody from the same mouse. Resected human lung tissue was not stained with PIMO. Effective magnification, 10.
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caseation (Fig. 1M and 2A). Of these solid lesions, 16% demon-
strated central PIMO activation (Fig. 2B). The majority of the
primate lesions (66%) showed significant evidence of central ca-
seous necrosis, and 100% of the lesions of this type showed
evidence of PIMO activation, as shown in Fig. 1P. Areas of dis-
organized inflammatory infiltration were also observed in the
lungs of three macaques, and as observed for the guinea pigs,
these infiltrates did not show evidence of PIMO activation.
PIMO adduct formation in rabbits was responsive to changes
in O2 tension. To confirm that the formation of the PIMO
adduct was in fact oxygen dependent in the TB model, we
housed two infected NZW rabbits in an atmosphere of Car-
bogen (95% O2–5% CO2) for 4 h prior to PIMO infusion and
during PIMO clearance (16 h). After exposure, rabbits were
necropsied, and serial sections of the tissues were analyzed for
PIMO activation by readers blinded to the treatment of the
animals. PIMO staining was greatly reduced in solid and case-
ous granulomas of these rabbits compared to staining of sim-
ilar-sized granulomas of rabbits housed in normal room air,
infused with PIMO, and necropsied at the same time (Fig. 3A
and B).
Direct measurement of oxygen tension in infected rabbits.
We used a fiber optic probe containing both a temperature
sensor and a non-O2-consuming pO2 sensor to measure the
pO2 directly in the lungs of live rabbits infected with either M.
bovis or M. tuberculosis. NZW rabbits (uninfected or infected
for 6 to 8 weeks) were anesthetized, intubated, and ventilated
with medical air (21% O2) prior to the opening of a window in
the fifth intercostal space on the right side (Fig. 4A). For each
rabbit, alternating measurements were taken in apparently
normal lung and in granulomatous lesions if present. Each
measurement was taken by inserting the needle-sheathed
probe through the plural surface of the lung and then retract-
ing the needle to position the probe tip 2 mm into the
targeted tissue. The probe was held in place for 1 min, and
continuous measurements of temperature and pO2 were re-
corded (Fig. 4C). Traces of data from three different granulo-
mas and one site in the normal lung of a single animal are
shown in Fig. 4C. The mean pO2 (	 standard error [SE]) for
the grossly normal lungs of infected rabbits (n  7) was 59.46 	
5.03 mm Hg, not significantly different from the mean mea-
surement for uninfected rabbits (64.15 	 9.71 mm Hg) (Fig.
4D). Granulomas of 3 to 5 mm in M. bovis- and M. tuberculosis-
infected rabbits had mean (	 SE) pO2 measurements of 2.66 	
0.70 mm Hg and 1.61 	 0.37 mm Hg, respectively. These
oxygen partial pressures found in tuberculous lesions were
significantly lower than those in the normal lung tissue (P 
0.001). Granulomas smaller than 3 mm could not be reliably
FIG. 2. Summary of pimonidazole staining by species and lesion
type. (A) Summary of the distribution of granulomas, showing solid
and caseous histology in each animal model. (B) Proportion of each
granuloma type labeling with anti-PIMO in the animal models. Mo,
mouse; Gp, guinea pig; Rb, rabbit; Mk, macaque. Open bars, solid
granulomas; filled bars, caseous/necrotic granulomas.
FIG. 3. Pimonidazole adduct formation is O2 dependent in the
rabbit model. (A) Necrotic granulomas showed reduced staining for
activated PIMO adducts (brown coloring) after infected rabbits were
housed under a 95% O2 atmosphere during PIMO exposure.
(B) Granuloma stained for activated PIMO adducts after infected
rabbits were housed in normal room air. A representative granuloma
is shown. Effective magnification, 100.
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measured in the ventilated lung tissue, and the few larger
granulomas observed had similar pO2 values. Histological ex-
amination of the analyzed lesions showed caseous necrotic
centers in each of the lesions measured and evidence of PIMO
activation (Fig. 4B).
Efficacy of Mtz in infected rabbits. The sensitivity of M. bovis
Ravenel to Mtz was first compared with that of M. tuberculosis
H37Rv in the Wayne model of nonreplicating persistence. M.
bovis Ravenel and M. tuberculosis had similar sensitivities to
Mtz in the nonreplicating persistence 2 model (a 1.3 log re-
duction in CFU after 50 M exposure for 7 days [data not
shown]). Twenty-seven NZW rabbits were infected by aero-
genic exposure to nebulized M. bovis Ravenel. Infection re-
sulted in a mean of 101 CFU/rabbit lung (range, 76 to 141
CFU/lung) 2 h after aerogenic infection and generated an
average of 53.5 granulomas (SE, 	15.5) in six untreated ani-
mals 10 weeks after infection. The remaining animals were
housed for 5 weeks before being randomized into three groups
(n  6). Control animals received vehicle (raspberry syrup)
only, Rif-treated animals received 10 mg/kg Rif in vehicle
daily, and Mtz-treated animals received 20 mg/kg Mtz in vehi-
cle twice daily. All groups were treated for 28 consecutive days.
Following 4 weeks of therapy, animals were sacrificed, and
the middle lobe of each right lung was weighed, homogenized,
and plated for colony enumeration, while upper and lower left
lobes were dissected into individual, discrete granulomas. Sev-
eral representative granulomas from each rabbit were excised,
homogenized, and plated for CFU enumeration. Slices of
grossly normal lung (0.5 g) were also homogenized and plated;
these samples consistently had 20 CFU/g of lung. The results
of one of two experiments are shown in Fig. 5. Treatment of
these animals with Rif for 4 weeks resulted in a 0.73 	 0.19
(mean 	 SE) log decrease in overall CFU/g lung (P  0.0052)
and a 0.9	 0.20 log decrease in CFU/granuloma (P 0.0004).
Treatment with Mtz resulted in a comparable decrease in
CFU/g of lung and CFU/granuloma (1.09 	 0.0.25 [P  0.001]
and 1.02 	 0.26 [P  0.0001], respectively). A second experi-
ment yielded essentially the same results.
FIG. 4. Measurement of pO2 in granulomas of M. tuberculosis complex-infected rabbits using a fiber optic oxygen probe. (A) After intubation and
ventilation with medical air, a thoracotomy was performed and rib spreaders were used to open the thorax. The oxygen probe (sheathed in a 22-gauge
needle) was inserted into visible granulomas or apparently normal portions of the lung. (B) Immunohistochemistry of an M. tuberculosis-induced
granuloma for the hypoxia marker PIMO. Shown is a representative granuloma where pO2 was measured (original magnification, 50). (C) Repre-
sentative traces of the response to the fiber optic pO2-temperature probe upon insertion into normal lung or granulomas within the same rabbit. The
probe was maintained in position for 1 min in each location. (D) Summary of direct measurements of pO2 with the fiber optic probe in lungs of
uninfected rabbits (norm), grossly normal lungs in infected rabbits (norm inf), granulomas of M. bovis-infected rabbits (Mb gran), and granulomas of M.
tuberculosis-infected rabbits (Mtb gran). Two to five granulomatous lesions (diameters, 3 to 5 mm) and two to three macroscopically normal areas were
measured in the right medial and caudal lobes of seven infected rabbits. Two to three measurements were made in the same region for three uninfected
rabbits. Each time the system was used or a probe was changed, the probe function was confirmed by measurement of pO2 in humidified 35 to 37°C room
air (151 mm Hg) and the fourth intercostal muscle (25 mm Hg). For each group of measurements, the horizontal line and error bar represent the
mean and standard deviation. The difference in pO2 was significant between normal lung tissue and either type of granuloma (P 0.001), but there was
no significant difference in pO2 between normal-appearing lungs in uninfected or infected rabbits (P  0.05) by using one way ANOVA with Tukey’s
posttest.
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To further confirm that this was not an M. bovis-specific
effect, a similar treatment experiment with M. bovis Ravenel
was conducted for C57BL/6 mice. Infected mice were housed
for 5 weeks after low-dose aerosol infection before being ran-
domized into PBS, Rif (10 mg/kg once daily), or Mtz (20 mg/kg
twice daily) treatment groups. Treatment was delivered for 28
consecutive days, followed by sacrifice and lung CFU enumer-
ation. There was no significant difference between CFU counts
in lungs from control (PBS) and Mtz-treated animals, while the
Rif treated animals showed a 2-log-unit reduction in CFU over
the treatment period (data not shown).
DISCUSSION
While the types of inflammatory cells that constitute a gran-
uloma appear to be the same among various animal models
and in human disease, the organization and architecture differ
considerably. In this study, we show that oxygen tension is
reduced in necrotic, highly organized granulomas formed by
guinea pigs, rabbits, and nonhuman primates, as evidenced by
the formation of a stable adduct between reduced pimonida-
zole and host proteins. In all three animal models, both solid
(cellular) and caseous (necrotic) lesions were present. The
caseous granulomas uniformly stained positively for activated
PIMO adducts, while the majority of solid granulomas showed
little or no staining. Thus, there was nearly perfect concor-
dance between areas of necrosis and apparent reduced oxygen
tension. It is not likely that this was due to differential pene-
tration of the drug into these similar lesions, because PIMO
has been shown to penetrate even dense tumor tissue and has
a high volume of distribution (1). We further show that in
rabbits, the reduction in oxygen tension is profound (in the
range of 2 mm of Hg) by using a fiber optic oxygen sensor
inserted directly into lesions in live infected animals. This 20-
fold reduction in oxygen concentration is sufficient to render
the bacilli sensitive to the hypoxia-specific drug Mtz.
Murine M. tuberculosis lesions have recently been shown to
have slightly lowered pO2 (37 mm Hg), but this is not suffi-
ciently hypoxic to cause PIMO adduct formation (3) or to
result in labeling with another hypoxia marker, EF5 (39). Con-
sistent with our results, Lenearts and colleagues (23) recently
demonstrated that some primary guinea pig lesions stain pos-
itively for PIMO adduct formation and hypothesized that the
hypoxic lesions may be a site of persistent infection.
The presence of hypoxic microenvironments within some
granulomatous lesions has the potential to alter the metabo-
lism of M. tuberculosis through induction of the oxygen-sensi-
tive dosR transcriptional regulon and therefore to alter suscep-
tibility to certain antituberculosis agents (42). In fact, one of
the defining characteristics of anaerobically adapted M. tuber-
culosis in vitro is sensitivity to Mtz (45), a drug with potent
anti-anaerobe activity that has been evaluated in mouse mod-
els by several authors. In one murine study using the Cornell
model of latent disease, addition of Mtz to either the steriliza-
tion phase or the “latent” phase of the model did not reduce
the likelihood of relapse (11). In a second study, Mtz had no
utility either as monotherapy or in combination with isoniazid
during early active infection; however, Mtz treatment during
chronic infection produced a small but significant reduction in
the pulmonary bacillary load (6). In a third study, Mtz com-
bined with isoniazid or Rif late in the course of treatment
resulted in a slight reduction in bacillary loads in lung and
spleen (28). In aggregate, then, the data for mice are consistent
with a largely normoxic environment in murine granulomas.
The results showing lack of activity in mice are unlikely to be
due to poor pharmacokinetics of the drug, since previous stud-
ies have demonstrated comparable exposure for this strain of
mice (5). Our data in the rabbit model demonstrate that Mtz
had antimycobacterial efficacy as potent as that of Rif, the
cornerstone of modern TB chemotherapy. One small study of
Mtz with humans did report clinical benefit in the radiographic
resolution of TB in patients but focused primarily on the rate
of sputum conversion and concluded that this agent had little
utility (10). Sputum-borne organisms would not be expected to
be affected by Mtz, because they are most likely to have been
exposed to oxygen while at the well-oxygenated surfaces of
pulmonary lesions. It remains to be seen whether Mtz will have
a significant benefit for human TB patients, but clinical trials to
explore this possibility are under way (http://clinicaltrials.gov,
ID number NCT00425113).
These studies demonstrate that valuable information can be
obtained from animal models of tuberculous chemotherapy
that develop hypoxic lesions and highly structured, necrotic
granulomas (14, 27). Hypoxia is, of course, only one physical
characteristic of necrotic lesions that distinguishes them from
cavities and other granulomas. Additional work to define all of
the important parameters affecting bacillary metabolism in the
full spectrum of lesions found will allow a rational approach to
identifying vulnerable elements in nonreplicating bacteria and
enable the development of strategies to rapidly eradicate these
recalcitrant populations.
FIG. 5. Metronidazole treatment of M. bovis Ravenel-infected rab-
bits is as effective as rifampin in reducing the burden of viable bacilli.
(A) Number of M. bovis CFU in the right middle lobe per gram of lung
tissue of rabbits given 28 days of drug therapy with Mtz (M), Rif (R),
or vehicle only (C) (n  6 per group). A one-way ANOVA analysis
returned a P value of 0.0001; the Bonferroni multiple-comparison
test returned P values of 0.001 (*) for Mtz and 0.0052 (**) for Rif
compared to the control. (B) Number of M. bovis CFU per individual
1- to 1.5-mm granuloma in the same experiment. P  0.0001 by
ANOVA. By the Bonferroni multiple-comparison test, P  0.0001 (*)
for Mtz (n 17) and P 0.0004 (**) for Rif (n 19) compared to the
control (n  16).
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